Turning tregs into class I suppressors

Blood

Volumn 119, Issue 15, 2012, Pages 3373-3374

  Geiger, Terrence L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ALLOIMMUNITY; ANTIGEN RECOGNITION; AUTOIMMUNITY; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

EID: 84859833062     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410969     Document Type: Note

References (7)

1. Plesa G, Zheng L, Medvec A, et al. TCR affinity and specificity requirements for human regulatory T-cell function. Blood. 2012;119(15):3420- 3430.
2. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory Tcells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531-564.
3. Edinger M, Hoffmann P. RegulatoryTcells in stem cell transplantation: strategies and first clinical experiences. Curr Opin Immunol. 2011;23(5):679-684.
4. Park TS, Rosenberg SA, Morgan RA. Treating cancer with genetically engineeredTcells. Trends Biotechnol. 2011;29(11):550-557.
5. Janeway CA Jr. TheTcell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 inT cell activation. Annu Rev Immunol. 1992;10:645-674.
6. Valitutti S, Muller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxicTlymphocytes by different levels ofTcell receptor occupancy. J Exp Med. 1996;183(4):1917-1921. (Pubitemid 26134333)
7. Zanin-Zhorov A, Dustin ML, Blazar BR. PKC-theta function at the immunological synapse: prospects for therapeutic targeting. Trends Immunol. 2011;32(8):358-363.